Publication
Phase II, randomized trial of preoperative epirubicin-paclitaxel +/− gefitinib with biomarker evaluation in operable breast cancer
Valentina Guarneri, Antonio Frassoldati, Guido Ficarra, Fabio Puglisi, Claudia Andreetta, Andrea Michelotti, Nicola Cresti, Corrado Boni, Giancarlo Bisagni, Rossana Berardi, Nicola Battelli, Armando Santoro, Giuseppe Banna, Alberto Bottini, Beatrice Di Blasio, Antonino Maiorana, Federico Piacentini, Simona Giovannelli, Gordana Jovic, PierFranco Conte
Breast Cancer Research and Treatment, August 2007, Springer Science + Business Media
DOI: 10.1007/s10549-007-9688-3